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“Before I came here, I was confused about this subject. Having listened to your lecture, I am
still confused – but on a higher level.”
Enrico Fermi
“Thanks to my solid academic training, today I can write hundreds of words on virtually any
topic without possessing a shred of information, which is how I got a good job in journalism.”
Dave Barry
ii
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Abstract
Dr. Richard Andrew Taylor
Doctor of Medicine
Medically Applied Artificial Intelligence: From Bench to Bedside
by Nicholas CHEDID
The intent of this thesis was to develop several medically applied artificial intel-
ligence programs, which can be considered either clinical decision support tools or pro-
grams which make the development of such tools more feasible. The first two projects
are more basic or "bench" in focus, while the final project is more translational. The first
program involves the creation of a residual neural network to automatically detect the
presence of pericardial effusions in point-of-care echocardiography and currently has
an accuracy of 71%. The second program involves the development of a sub-type of
generative adverserial network to create synthetic x-rays of fractures for several pur-
poses including data augmentation for the training of a neural network to automat-
ically detect fractures. We have already generated high quality synthetic x-rays. We
are currently using structural similarity index measurements and Visual Turing tests
with three radiologists in order to further evaluate image quality. The final project
involves the development of neural networks for audio and visual analysis of 30 sec-
onds of video to diagnose and monitor treatment of depression. Our current root mean
square error (RMSE) is 9.53 for video analysis and 11.6 for audio analysis, which are
currently second best in the literature and still improving. Clinical pilot studies for this
final project are underway. The gathered clinical data will be first-in-class and orders
of magnitude greater than other related datasets and should allow our accuracy to be
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Chapter 1
Deep Learning for the Detection of
Pericardial Effusions in the
Emergent Setting
1.1 Introduction
1.1.1 Ultrasound for Pericardial Effusion
The first ultrasound was introduced in the 1950s but would not become widely uti-
lized in clinical practice until the 1970s [1]. Real-time ultrasound was developed in the
1980s, which allowed for adoption in emergent settings [1]. Since then, Point-of-Care
Ultrasound (POCUS) has become an increasingly important diagnostic tool utilized in
the emergency department, and there has been significant research towards improving
ultrasound techniques for the evaluation of a wide variety of clinical conditions [1, 2, 3].
One such condition for which ultrasound has been utilized is pericardial effu-
sion. Ultrasound is the preferred diagnostic tool for pericardial effusion given it is fast,
accurate, widely available, and non-invasive [4].
However, while some physicians have specific extended training using ultra-
sonography, there is concern regarding diagnostic variability between those who have
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this training compared to those who do not. This raises the concern for potential for er-
ror in the diagnosis of pericardial effusion in the emergency room. In a study published
in Academic Emergency Medicine, residents and faculty from an emergency medicine
training program at a Level 1 trauma center were asked to view ultrasound clips in pa-
tients with chest trauma [5]. The overall sensitivity was 73% and specificity was 44%.
Given the possible emergent nature of pericardial effusion and the importance of rapid
and accurate diagnosis, a diagnostic or clinical decision support tool to reduce error
would likely be of significant benefit. A form of artificial intelligence (AI) increasingly
used for imaging purposes called a convolutional neural net (CNN) may be able to
serve as such a tool.
1.1.2 Use of Neural Networks in Medical Imaging
Medical imaging can be broken down into two basic components: image acquisition
and image interpretation. Image acquisition has improved greatly over the past decades
with significantly increased acquisition speed and accuracy; however, improvements
to image interpretation have been much slower to manifest. This is particularly due to
the fact that the image interpretation process has primarily been a human not a tech-
nologically driven process with most interpretations performed by physicians. This
comes with many of the limitations associated with a human-driven process such as
subjectivity, human error, fatigue, limited interpretation speed, and significant vari-
ability among providers. Technological aids to the image interpretation process have
only recently begun to be developed.
One such aid is machine learning (ML). ML is an application of AI that allows
systems to automatically learn and improve from experience without being explicitly
programmed. Machine learning has been increasingly used for medical imaging tasks
particularly in the fields of radiology and pathology [6]. A specific machine learn-
ing technique called a deep convolutional neural network (CNN) has become the new
gold-standard machine learning technique in medical imaging research [7].
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Neural networks are inspired by the structure and function of a biological ner-
vous system. A neural network is composed of neuronal layers just as a nervous sys-
tem is composed of layers of neurons. Each neuron in a neural network is connected to
neurons in the prior and subsequent neuronal layer but not to neurons within the same
layer. Each of these connections is associated with a certain weight value. Each neuron
can be thought of as a logistic regression function. Each time the model runs forward
it ends with a final error value. The model then runs backward in order to attach new
weights to each of the parameters based on the error. This process is repeated until
the error stabilizes at a minimum value. Once a neural network has been optimally
trained on a set of images to have maximal accuracy in identifying them correctly, it is
then tested on a completely novel set of images to see if its predictive capabilities can
generalize to fresh images.
Neural networks have been used for a wide variety of medical applications in-
cluding classification of skin cancer from pathology images [8], detection of pneumonia
on chest X-rays [9], and detection of polyps during colonoscopy [10].
The use of neural networks in ultrasounds is much less developed due to sev-
eral difficulties associated with ultrasound. Ultrasound can be more complex than
other imaging modalities, which often contain a single still frame, because it consists
of video containing many frames, with very little labeled information. Ultrasound
also has decreased resolution compared to other imaging modalities such as CT and
MRI. Additionally, for echocardiograms in particular, measurements and the visible
anatomy can vary significantly with the beating of the heart. Preliminary work using
neural networks for echocardiography has been performed showing an ability to de-
tect hypertrophic cardiomyopathy and cardiac amyloidosis with C-statistics of 0.93 and
0.84 [11]. However there has been very little work conducted on ultrasound acquired
in the point-of-care setting.
Chapter 1. Deep Learning for the Detection of Pericardial Effusions in the Emergent
Setting
4
1.1.3 Need for Data: a Call for Multicenter Collaboration
Perhaps the most important variable in creating a high performing neural network is
the sheer quantity of labeled data needed, for example, ultrasounds labeled as effusion
present or absent. A larger dataset provides more material for the neural net to learn
from enabling greater final accuracy.
Given the vast amount of data necessary to train high performing machine
learning algorithms, the quantity of data needed often quickly outstrips that available
at a single institution; this has led to some in the field calling for increased multicenter
collaborations [12, 13].
In this paper, we aim to demonstrate a proof-of-concept neural network for
a clinical decision support tool for pericardial effusion in the emergent setting while
highlighting the need for increased multicenter collaboration for the development of
high performing neural networks.
1.2 Methods
1.2.1 Image Acquisition and Classification
Image acquisition and classification was done primarily by Nicholas Chedid.
Echocardiograms in the DICOM format were manually gathered using the Emer-
gency Department’s picture archiving and communication system (QPath). Ultrasounds
were chosen sequentially from all adult patients (≥ 18 years) who had an ED echocar-
diogram performed within the period March 2013 to May 2017. These ultrasounds
were interpreted and labeled by the resident or attending physician who acquired
them. Only echocardiograms taken in the parasternal long axis view were included
(for optimal visualization of a wider range of cardiac pathology). Additionally only
echocardiograms with at least two documented readings by physicians (including at
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least one by an attending physician) were included. All echocardiograms and interpre-
tations were also reviewed by me for inclusion. These DICOMs selected for inclusion
were saved in a Yale Secure Box folder. Additionally, an Excel spreadsheet was cre-
ated to organize information relevant to each DICOM. Each DICOM was recorded nu-
merically and several associated characteristics were manually transcribed including:
medical record number (MRN), account number, accession number, date of the study,
effusion status (present or absent), equality status (presence or absence of strain), exit
status (dilated or normal), ejection fraction status (depressed, <50%, normal, 50 - 65%,
hyperdynamic >65%), and number of studies associated with each encounter. This re-
sulted in a dataset consisting of 1545 videos from 1515 patients. For this study, only
those videos that specifically commented on the presence or absence of pericardial ef-
fusion were included. This resulted in 272 videos.
These videos were then fed through an image preprocessing Docker package
created by collaborator Adrian Haimovich. Preprocessing included anonymization
by stripping of all identifying metadata and splitting into still frames. Our utlimate
dataset consisted of 12,942 still frames. Our training dataset consisted of 80% of these
frames (10,299) and our test dataset consisted of the remaining 20% (2643).
1.2.2 ResNet 20
Work for building and tuning the ResNet architecture was done primarily by Nicholas
Chedid
A neural network was developed using Python scripts and programs using
Keras packages running on a Theano backend. Specifically the subtype of convolu-
tional neural network created was a 20-layer residual network, a gold-standard neural
network for image classification and computer vision tasks, which won the Imagenet
challenge in 2015 (ResNet-20) [14]. Plain deep networks can be difficult to train be-
cause of vanishing and exploding gradients. By using stacked Residual Blocks, which
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use skip connections that take activations of one layer and feed them to much deeper
layers, ResNets are able to be built much deeper.
Our network has 20 weighted layers with shortcut connections inserted. Our
convolutional layers mostly have 3x3 filters and are designed so that: (1) for the same
output feature map size, the layers have the same number of filters; and (2) if the fea-
ture map size is halved, the number of filters is doubled so as to preserve the time
complexity per layer. Downsampling was performed directly by convolutional lay-
ers with a stride of 2. The network ends with a global average pooling layer and a
1000-way fully-connected layer with softmax. L2 regularization was utilized to reduce
overfitting. Batch normalization was used to speed up training and increase accuracy.
Activation functions primarily consisted of recitified linear units (ReLU) except for the
softmax classifier layer.
Many different training iterations were run for hyperparameter tuning in order
to optimize the neural network’s accuracy on the test set. Tunable variables included:
number of epochs, ResNet Model (i.e. number of layers), learning rate, L2 Regular-
ization coefficient, batch size, and data augmentation features including: featurewise
center, samplewise center, featurewise standard normalization, samplewise standard
normalization, zca whitening, rotation range, width shift range, height shift range, hor-
izontal flip, and vertical flip.
The optimal neural net was one in which epochs were set to 50, ResNet Model
(i.e. number of layers) was set to 20, learning rate was set to 0.001, L2 Regularization
coefficient was set to 1.00E-03, batch size was 16, and the following data augmentation
features were set to: featurewise center = off, samplewise center = off, featurewise
standard normalization = off, samplewise standard normalization = off, zca whitening
= off, rotation range = 180, width shift range = 0.15, height shift range = 0.15, horizontal
flip = on, and vertical flip = on.
Training was performed over nearly 19 hours on a desktop computer with 3
Titan X NVIDIA graphics cards with 8 GB RAM each.
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The number of layers and the batch size were not able to be further increased
due to system constraints . Fortunately deepening of the ResNet past 20 layers did not
seem to significantly improve tests accuracy across 200 epochs (accuracy remained at
92%) from ResNet20 to ResNet110 as seen in He et al. [14]. Code availability: ResNet is
publicly available on Github.
1.3 Results
After running the aforementioned ResNet for 200 epochs, we were able to achieve a
final test accuracy of 71%. Our results can be seen in Table 1.1.
The table is organized into three columns with percentage of our total dataset
used for training in the left column, our final test accuracy in the middle column, and
our final train accuracy in the right hand column. The final train accuracy remained
fairly consistent ranging from 74 - 81%. More importantly, it can be seen that the test
accuracy improved from 49 to 71% as the amount of data used to train our ResNet
increased from 20 to 80% illustrating the continual improvement associated with in-
creasing available training data.
TABLE 1.1: Neural Network Performance in Identifying Presence or Ab-
sence of Pericardial Effusion
% of dataset used Final Test Accuracy Final Train Accuracy
25% of 80 = 20% 49% 75%
50% of 80 = 40% 42% 81%
75% of 80 = 60% 57% 78%
Full(80%) 71% 74%
1.4 Discussion
We have demonstrated the creation of a proof-of-concept neural network for a clinical
decision support tool for pericardial effusion in the emergent setting with an accuracy
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of 71% compared to a sensitivity of 73% and specificity of 44% for the detection of peri-
cardial effusions by academic emergency medicine physicians [5]. We are currently in
the process of writing code that would allow us to assess the sensitivity and specificity
of our program as well.
The accuracy of our neural network showed step-wise improvement as we used
increasing percentages of our available data. Given the fact that our training data came
from one of the highest volume EDs in the United States (Yale New Haven Hospital
has a very high volume ED with the 3rd most ER visits in 2016 [15]) and our results
suggest likely continual improvement with even more data, this highlights the need
for multicenter collaboration to aggregate sufficient training data to train very high
performance algorithms that can aid in clinical decision making.
Future steps include writing code that would allow us to assess the sensitivity
and specificity of our program as well as several steps that may help improve our
accuracy further such as incorporating transfer learning from a ConvNet pre-trained
on ImagNet, reformatting input data from still frames to short video clips as this may
improve performance, using a Generative Adversarial Network (GAN) instead of a
ResNet, and using segmentations to improve performance.
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Chapter 2
Fracture X-Ray Synthesis with
Generative Adversarial Networks
2.1 Introduction
2.1.1 Fractures in the Emergency Department
Fractures are among the most common reasons for emergency department visits. While
some fractures are easily discernible on x-ray, many others are subtle enough to require
a radiologist’s inspection for a definitive diagnosis. In the fast-paced environment of
the emergency department, the subtleties in fracture diagnosis can sometimes be over-
looked or misinterpreted, leading to medical error. This phenomenon has been quanti-
fied before: A four-year study in a busy district general emergency department found
953 diagnostic errors, of which 760 (79.7%) were missed fractures [16]. The primary
reason for diagnostic error in 624 of 760 (82.1%) of these patients with fractures was a
failure to interpret radiographs correctly [16].
The annual incidence of fractures has been estimated to be as high as 100.2 per
10,000 in males and 81.0 per 10,000 in females [17].
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Additionally delay in appropriate diagnosis may lead to worsened clinical out-
comes and increased healthcare costs. Medical errors cost the United States $17 billion
in 2008 [18].
A technology that can automatically detect fractures has the potential to reduce
emergency department medical errors, costs, and waiting times. However, training im-
age analysis algorithms often requires hundreds or thousands of manually annotated
examples. The process of annotating these examples can be labor and time intensive.
The process of developing automatic fracture detectors is even more burden-
some given that there are many different types of fracture, which would require train-
ing many different types of detectors. Hundreds to thousands of images would have
to be manually annotated to train each of these detectors. Fortunately, here we de-
scribe a method to greatly simply the training of a multitude of automatic fracture
detectors. This method entails the creation of synthetic x-rays from procedurally gen-
erated segmentations, thereby creating annotated datasets with minimal human time
expenditure.
Data augmentation is the process of increasing the total information provided
by a training dataset by generating many variants of datapoints within the dataset.
In the context of images, this often involves simple transformations such as rotation,
scaling, and translation. Training an algorithm on many examples of the same images
that are rotated by different amounts can teach that algorithm rotational invariance;
training it on many resized examples of an image can teach invariance to scale and so
on.
However simple image transformations are unable to teach invariance to more
subtle features. Generating synthetic images to augment training data sets may im-
prove invariance to these more subtle features. In this work, we demonstrate that it
is possible to generate synthetic x-ray images using image-to-image synthesis for the
purpose of data augmentation.
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2.1.2 Image-to-Image Synthesis
Image-to-Image synthesis is the process of converting an image from an element of one
domain to an equivalent image from an element of another domain.
Training image-to-image synthesis algorithms is notoriously difficult because
image-to-image synthesis is an underconstrained problem. There are many correct so-
lutions to any image-to-image synthesis problem.
A generative adversarial network (GAN) is a generative model that is trained in
an adversarial process between two sub-networks: a generative model G and a discrim-
inative model D. G learns to generate synthetic simulations of images from a particular
domain while D learns to discriminate between true images from that domain and syn-
thetic imitations generated G. This is an adversarial process in the sense that these two
networks are trained in opposition. Generally optimization of one’s network’s perfor-
mance will lead to deterioration of the other’s. Thus an ideal, unique solution exists
where G recovers the training data distribution and D is equal to 12 everywhere.
2.1.3 Prior Work
Chuquicusma et al. [19] used generative adversarial networks (GANs) to create syn-
thetic lung cancer nodules and place them in computed tomography (CT) images. The
overall quality of these synthesized nodules was then evaluated using a “Visual Turing
test,” which consisted of having two radiologists evaluate images with either real or
synthetic nodules and try to distinguish between the two. The creation of synthetic
lung nodules via GANs was a novel concept. Possible next steps might include: us-
ing quantitative measures of image synthesis such as a structural similarity index in
addition to the qualitative Visual Turing test, using the pix2pixHD method which may
be an interesting way of generating higher resolution images, and generating entirely
synthetic images as opposed to a component within the image (e.g. lung nodules).
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Korkinof et al. [20] used GANs to generate synthetic mammograms. The overall
quality of these synthetic images was evaluated qualitatively by comparing them vi-
sually to real mammograms. The creation of synthetic high-resolution mammograms
via GANs was a novel concept. Possible next steps might include: using more rigorous
qualitative assessments of image synthesis such as the Visual Turing Test by experts
used by Chuquicusma et al., using quantitative measures of image synthesis such as
a structural similarity index, and by using the pix2pixHD method which may be an
interesting way of generating even higher resolution images.
2.2 Methods
2.2.1 Network Architecture
This work uses the pix2pixHD network architecture described by Wang et al. [21]. The
pix2pixHD method improves upon GANs by introducing a coarse-to-fine generator
and multi-scale discriminator architecture which allows for image generation at a much
higher resolution with an order of magnitude less memory.
The coarse-to-fine generator consists of a global generator network G1 and a
local enhancer network G2. The architecture of the global generator G1 is that pro-
posed by Johnson et al. [22]: a convolutional front-end, a set of residual blocks, and
a transposed convolutional back-end. The architecture of the local enhancer network
G2 is the same except that the input to the residual blocks consists of the element-wise
sum of not only the feature maps from the convolutional front-end of G2 but also the
last feature map of the transposed convolutional back-end of G1, which helps integrate
information from the global network.
The coarse-to-fine moniker describes the training method of the generator. First,
G1 is trained on lower resolution versions of the original training images, then G2 is ap-
pended to G1, and finally the two networks are trained together on the full resolution,
Chapter 2. Fracture X-Ray Synthesis with Generative Adversarial Networks 13
original images.
Utilizing the coarse-to-fine generator to produce higher resolution synthetic im-
ages poses a novel challenge however. Traditional GAN discriminator design does
not perform as well on these higher resolution images because to distinguish between
higher resolution real and synthetic images it would be necessary to use a discrimina-
tor with a large receptive field. This could be accomplished by either using a deeper
network or larger convolutional kernels both of which could potentially cause overfit-
ting and would require significantly more memory for training. This was addressed by
Wang et al. in the design of their multi-scale discriminator consisting of three discriminators—
D1, D2, and D3—with identical network structures but organized in a pyramid struc-
ture in which each discriminator operates at different image scales funneling from
lower to higher image resolutions as seen in Figure 2.1.
FIGURE 2.1: Multi-scale Discriminator: D1, D2, and D3 are the three dis-
criminators that make up the multi-scale discriminator. Each has the
same architecture. They are multi-scale in that they form a pyramid
structure with each operating at a smaller scale with correspondingly
smaller receptive fields from D3 to D1.
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2.2.2 Image Acquisition and Preprocessing
Image Acquisition and preprocessing work was done primarily by Nicholas Chedid.
50 x-rays of femoral fractures were downloaded from an internet search. Using
a small initial dataset of 50 images aligns with the goals of this work to show how a
pix2pixHD pipeline could allow for a rapidly scalable tool to aid in data augmenta-
tion of many fracture types while reducing manual work and the need for very large
databases. The difficulty in acquiring and the manual work necessary to use a dataset
of this size is much less than what would be needed to acquire and label a traditional
dataset of several hundred to thousands of images for training a single fracture detec-
tion algorithm. Not only might time and manual labor be significantly reduced via the
creation of a pix2pixHD pipeline, but the training of accurate neural networks that may
have previously been hampered by a lack of original data may be possible.
The 22 highest quality images were then chosen for training and testing pur-
poses. Afterwards, artifacts and labels were removed from these 22 x-rays using the
GNU Image Manipulation Program (GIMP). Segmentations of these images were cre-
ated using the GIMP software package by drawing arcs and lines to represent bones
and soft tissue. Both the x-ray images as well as the segmentations were then converted
to squares and resized to 1024 x 1024 pixels in order to be input into the pix2pixHD
model. The segmentations were further processed by having their RGB pixels pro-
grammatically converted to all 0s and 1s as the final step in order to utilize them as
input to the pix2pixHD model. This work can be seen in Figures 2.2 and 2.3.
2.2.3 Training
Coding, debugging, and training of the pix2pixHD neural network was done by both
Nicholas Chedid and collaborator Praneeth Sadda.
Given our limited dataset of 22 x-rays and in order to improve the accuracy of
our pix2pixHD model, we utilized the leave-one-out cross-validation method, which is
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FIGURE 2.2: X-ray Preprocessing: The first row contains the original x-
ray images. The second row contains x-rays that were cleaned of artifacts
and labels by using the GIMP software package. The third row contains
the final version of the x-rays that have been programmatically resized
into 1024 x 1024 pixel squares in order to be input into the pix2pixHD
model.
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FIGURE 2.3: Segmentation Preprocessing: The first row contains the
bone and soft tissue segmentations of the x-ray images created using the
GIMP software package. The second row contains segmentations that
have been programmatically resized into 1024 x 1024 pixel squares. The
final row contains the resized segmentations, which have had their RGB
pixels programmatically converted to all 0s and 1s in order to be input
into the pix2pixHD model.
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commonly used in machine learning research to improve accuracy for models trained
on smaller databases [23, 24].
The leave-one-out cross-validation method works in the following manner. The
machine learning model, pix2pixHD in our case, is trained on all data points (images
in our case) except one which is reserved for testing. This process is then repeated
until every data point has been used for testing. So in our case, we utilized 21 im-
ages for training while reserving 1 for testing. This process was repeated for a total
of 22 variations in order to utilize every image as a testing image. This method helps
improve performance when one’s dataset is smaller by increasing the computational
burden. Namely, the parameters of the model are re-calculated repeatedly according to
the number of data points in the dataset. This means that if a machine learning model
such as pix2pixHD were to need a certain number of calculations (n) proportional to
the dataset size, then utilizing the leave-one-out cross-validation method would in-
stead require n2 calculations.
Fortunately this is the optimal method for this project since we are aiming to
show the scalability of our method for many fracture types and are therefore intention-
ally more data limited than computationally limited.
Another advantage of the leave-one-out cross-validation method is that, by us-
ing nearly the complete dataset for training for each iteration, it is believed to give the
most accurate estimate of the parameters, and, accordingly, the best estimation for how
the model would perform on new data (generalizability) [24].
The training data was assembled by pairing the segmentations with their asso-
ciated x-ray images while leaving one out for testing in the method described above.
Our networks were trained over 200 epochs. A learning rate of 0.0002 was used
for the first 100 epochs. The learning rate was then decayed in a linear manner to zero
over the next 100 epochs. Weights were initialized randomly following a Gaussian
distribution with a mean of 0.
Chapter 2. Fracture X-Ray Synthesis with Generative Adversarial Networks 18
2.2.4 Postprocessing: Denoising
In order to further improve image quality and reduce noise artifacts, the images pro-
duced by the pix2pix model will then be input into a convolutional denoising autoen-
coder before being assessed for quality via the Visual Turing Test and the Structural
Similarity Index Measurement Algorithm. Convolutional denoising autoencoders have
already shown great utility for the denoising of medical images [25].
2.2.5 Visual Turing Test
Recruitment of radiologists into this study was done primarily by Nicholas Chedid.
Code for displaying real vs synthetic x-rays to radiologists for assessment was written
by my collaborator Praneeth Sadda.
A Visual Turing Test for assessment of synthetic image quality produced by
GANs was proposed by Chuquicusma et al. [19]. We follow a similar methodology
here to evaluate our synthetic images.
We designed 10 Visual Turing Test experiments. Our experiments will be con-
ducted with three radiologists (one resident and two attendings). A radiology resident
and two attending MSK radiologists including the division chief have been recruited
The code for displaying the x-rays in these experiments has already been written.
Our experiments consist of 5 experiments of all generated x-rays and 5 of mixed
generated and real x-rays. Each experiment contains 9 images in a 3 by 3 grid. Radiolo-
gists will be allowed to zoom in or change the view of the image. For each experiment
the radiologists will be informed that the presented grid of images could consist of all
generated, all real, or a mixture of images. Radiologists will then be asked to identify
which images are real and which are generated. It is estimated that the total time for
each radiologist to complete these experiments will be less than 30 minutes.
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We will quantitatively measure the results from our Visual Turing Test and
therefore the quality of our synthetic x-rays by measuring inter-observer variations,
False Recognition Rate (FRR), and True Recognition Rate (TRR).
2.2.6 Structural Similarity Index Measurement (SSIM)
Assessment of pix2pix accuracy using the structural similarity assay will be done pri-
marily by Nicholas Chedid.
A more quantitative assessment of image synthesis quality can be performed
using a structural similarity index measurement (SSIM) as described by Wang et al. [26].
The SSIM is an objective method for assessing perceptual image quality. Previous
methods for assessing image quality such as mean squared error (MSE) and peak
signal-to-noise ratio estimate absolute errors, while SSIM is a quantitative model that
predicts perceived image quality, which is of more value given our work.
Once post-processing using a convolutional denoising autoencoder is completed,
I will run the SSIM.
2.3 Results
Our work has progressed through several stages. In my initial work I used plain GANs
to synthesize x-ray images from segmentations. In order to further improve this work,
we moved on to using the pix2pixHD method. This preliminary work utilized the
pix2pixHD method without the leave-one-out method and was also prior to removal
of artifacts and labels via the GIMP software package.
I presented these preliminary qualitative results (i.e. our synthetic x-ray images
without the leave-one-out method, with minimal preprocessing, without postprocess-
ing, and without the Visual Turing tests or SSIM data) as a poster titled, Deep-Learned
Generation of Synthetic X-Rays from Segmentations, at the International Conference on
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Medical Imaging and Case Reports in Baltimore, Maryland. These results can be seen
in Figure 2.4. It can be seen that synthetic x-rays closely resembling their associated
segmentations were able to be generated. However, ideally both improved resolution
and reduction in artifacts could be achieved. To this end, I have increased our dataset
from 13 to 22 x-rays and their segmentations and have removed artifacts and labels
from the original x-rays. Additionally as mentioned in Section 2.2.3, I am now imple-
menting the leave-one-out method and postprocessing using a denosing concolutional
autoencoder.
Preliminary results incorporating these changes can be seen in Figure 2.5. As
can be seen in said figure, artifacts have been decreased and resolution increased. Ide-
ally current work on postproccessing should further increase image quality.
FIGURE 2.4: The top row displays our previous programmatically gen-
erated segmentations from x-ray tracings and the bottom row displays
the corresponding synthetic x-rays generated from these segmentations
using the pix2pix method prior to our implementation of the leave-one-
out method and prior to the clean up of artifacts and labels from our
x-ray images.
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FIGURE 2.5: Examples of Generated X-rays: Here is a random selection
of the synthetic x-rays generated using the pix2pix method with imple-
mentation of the leave-one-out method. Following the completion of
postprocessing, quality should improve even further.
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Given valuable feedback from that conference, I also decided to incorporate
both the Visual Turing Test and the SSIM for evaluation of results.
2.3.1 Visual Turing Test
Once postprocessing using a convolutional denoising autoencoder is completed, these
updated synthetic x-rays will be used to conduct our Visual Turing Tests as outlined in
section 2.2.5. Code to conduct these tests has already been written. One of the 3 by 3
grids of generated vs real x-ray images to be used in the Visual Turing Test can be can
be seen in Figure 2.6.
We envision displaying our results from the Visual Turing Test experiments
(including FRR) in a manner similar to Chuquicusma et al.
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FIGURE 2.6: Generated vs Real X-rays Visual Turing Test Grid: This is
one of the 3 x 3 grids that will be utilized in the Visual Turing Tests. It
consists of both generated and real x-ray images. For illustrative pur-
poses here (i.e. in order to compare real and generated x-rays), the gen-
erated x-ray images have been given a pink highlighted outline.
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2.3.2 Structural Similarity Index Measurement (SSIM)
Once post-processing using a convolutional denoising autoencoder is completed, I will
implement a SSIM to quantitatively evaluate the perceptual similarity of these updated
synthetic x-rays to the original x-rays as described in section 2.2.6.
SSIM results will be reported in the format seen in Table 2.1.
Algorithm Avg. MSE Avg. SSIM
pix2pixHD 97.1 ± 34.6 97.1 ± 34.6
TABLE 2.1: Example table for SSIM results.
2.4 Discussion
It is possible to synthesize realistic x-rays from procedurally generated segmentations
with the pix2pix method. This can be seen qualitatively when comparing the syn-
thesized x-rays to the original x-rays. The quality of these synthesized x-rays will be
further quantified by our Visual Turing Test experiments and SSIM. Our study will be
the first to quantify generated medical images to such a rigorous extent.
This is the first work that we know of to quantify synthetically generated med-
ical images with a SSIM as well as the first to generate entire, synthetic x-ray images de
novo using the pix2pixHD method (a higher resolution modality) as well as the first to
measure the quality of entire, synthetic x-ray images using the Visual Turing Test.
We envision several ways in which the image synthesis method we have demon-
strated may be useful in improving automated fracture detectors. Neural networks
depend on supervised learning and are therefore limited by the availability of labeled
data. As mentioned above, image synthesis can be useful for data augmentation. For
example, when a fracture detector fails at classifying an image (e.g. as fracture present
or absent), one would wish to ideally retrain that detector on multiple closely related
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examples to improve its accuracy. Unfortunately one is limited by available data. For-
tunately using image synthesis would allow to generate closely related examples to
retrain the detector. Additionally our method could be a valuable way of generating
training data for x-ray segmentation algorithms.
Additionally the generation of synthetic examples using GANs has been used
for improving out of domain or novelty detection, meaning the ability of a classifier
to recognize unknown inputs, which could be another way to utilize our method for
improving automated fracture detectors particularly their generalizability.
Our trained synthesizer can also be used to better describe images (e.g. by learn-
ing features from the trained synthesizer).
Finally, these results were achieved by using only a small dataset compiled from
readily accessible data from an internet search. This was done to address our goal of
demonstrating how a pix2pixHD pipeline could be utilized as a rapidly scalable tool
to aid in data augmentation of automated fracture detectors for many fracture types
while reducing manual work and the need for very large databases.
The difficulty in acquiring and the manual work necessary to use a dataset of
this size is far less than what would be needed to acquire and label a traditional dataset
of several hundred to thousands of images for training a single fracture detection algo-
rithm. Additionally, this tool can easily be used for different fracture types with much
less work needed to switch between fracture types compared to the aforementioned
traditional methods.
An interesting next step would be to train several neural networks at different
tasks first by using small to moderately sized original databases and then by using
those same databases further augmented with synthetic images generated via rapidly
iterable customized versions of this pix2pixHD pipeline and then observe whether neu-
ral network performance was improved via this time and manual labor saving method.
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Chapter 3
Neural Networks for Depression
Screening & Treatment Monitoring
3.1 Introduction
3.1.1 Depression and it’s Diagnosis
Depression is a disease with tremendous impact upon the human race. Globally, over
350 million individuals suffer from depression per year [27], and The Substance Abuse
and Mental Health Services Administration estimates that approximately 16.2 million
adults in the United States had at least one major depressive episode in 2016 [28]. One
in five US adults are estimated to have experienced depression in their lifetime [29].
This problem is compounded in certain populations such as high functioning adults
with demanding careers (such as medical trainees or professionals), adolescents, and
the chronically ill [30].
In addition to being widespread, depression is associated with significant suf-
fering, disability, and mortality. It is estimated that depression accounts for more “years
lost” from disability than any other chronic disease by a wide margin [27]. This in-
cludes traditionally disabling conditions such as back pain, lung disease, and alcohol
abuse. Recent studies have also demonstrated those with depression have higher rates
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of obesity, heart disease, and diabetes [31, 32]. Finally, untreated major depression is
well known to be the highest risk factor for suicide [33, 34].
While many psychopharmacologic and psychotherapeutic treatments exist to
treat depression, self-recognition and diagnosis remain a formidable challenge. It is
estimated that around two-thirds of all cases of depression in the United States are
undiagnosed [35]. First, the diagnoses of depression and most psychiatric conditions
are based on clinical assessment by a physician, leaving potential for bias and inter-
physician variability. For example, according to the field trials of the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) there was high variabil-
ity between physicians even when assessing the same patient for depression with an
intraclass Kappa of 0.28 (95% CI: 0.20–0.35) [36, 37, 38]. Secondly, a formal diagno-
sis of depression requires a visit with a clinician, and individuals with limited access
to healthcare have higher levels of undiagnosed depression [39]. Finally, the subjec-
tive nature of the assessment of depression and infrequent or difficult to obtain mental
health appointments may lead to difficulties in longitudinal tracking of incremental
changes or declines in psychiatric state.
After diagnosis, one complexity in the treatment of major depressive disorder
is tracking response to therapy. After initiating a treatment, clinicians have to wait
weeks in order to assess the effectiveness of that specific therapy. This often leads to
lapses in care, and unfortunately even those with significant depression symptoms can
be unintentionally neglected. It is estimated that over a quarter of those who complete
suicide are undergoing treatment for their disease [33]. Clearly there remains an unful-
filled need to carefully monitor patients who are not so ill as to qualify for mandatory
inpatient admission.
Given the prevalence and severity of undiagnosed and undertreated depres-
sion, readily available and widely-implemented screening tools to recognize depres-
sion symptoms are vital to enhance overall public health. Acknowledging this issue,
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the U.S. Preventive Services Task Force (USPSTF) has recommended routine depres-
sion screening in primary care clinical practices [40]. Survey-based methods such as
the Patient Health Questionnaire (PHQ)-2 and PHQ-9 are the most commonly used
screening tools in the primary care setting [41]. However, these surveys take time, rely
upon patient interaction with a primary care doctor, and do not adequately address
the risk of developing depression symptoms in between often infrequent clinical vis-
its. They also do not allow for monitoring of treatment in between difficult-to-obtain
clinical visits. What is needed, and does not currently exist, is a solution to depression
screening that is scalable, easy to administer, timely, and allows continual assessment.
Here, we propose a digital tool that uses an AI-powered facial and language
recognition algorithm to screen for depression. The technology will use a 30-second
video of a face, which will be recorded by the user, and notably can be integrated into
any smartphone with a front-facing camera. The AI algorithm will then analyze the
video and audio samples to provide a real-time measurement of that user’s depression
risk. Those who are found to be at high risk for a major depressive episode will be
provided appropriate resources and/or a possible referral to a clinician or telepsyhi-
atry service for follow-up care. The technology will be user-friendly, accessible, and
accurate.
3.1.2 Prior Work
Even though major depression is a tremendous public health concern, it has lagged far
behind other diseases in recognition and strategy for research and cure. The study of
artificial intelligence is a rapidly growing field and, while its use has been explored
broadly in medicine, only recently has its use been directly studied to improve mental
health. Experienced psychiatrists rely on microexpressions and auditory cues when
evaluating patients for mental health disease; our hypothesis is that machine learning
can detect similar patterns to add to the growing armamentarium of screening tools
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in mental health. Others have suggested AI analysis can predict and diagnose depres-
sion [42], but most applications focus on using only a single modality, such as audio or
text and do not track changes in mood longitudinally.
Previous work on automatic depression detection has been conducted on the
Audio-Visual Emotion recognition Challenge (AVEC) datasets [42, 43, 44, 45, 46]. AVEC
is currently the only available source of audiovisual data with associated depression
ground truth labels. AVEC 2013 and 2014 provide video samples with corresponding
BDI-II scores, while more recent AVEC challenges provide interactive video samples
and transcriptions associated with PHQ-8 scores. We are focused on the BDI-II survey
(thus the AVEC 2014 dataset), as it is the depression survey used most commonly for
research purposes and because it is more granular (0-63 range of BDI-II scores versus 0-
23 range on PHQ-8; these additional questions provide a possible source of metadata).
The AVEC 2014 dataset consists of 150 interviews designed to evaluate patients
for depression. The dataset is divided into a 50 video training set, a 50 video develop-
ment set, and a 50 video testing set. Each video is associated with a BDI-II score that
can range from 0 to 63. The actual scores in the dataset range from 0 to 45, highlighting
the skew towards non-depressed patients. A higher BDI-II score is correlated with a
greater risk of depression. A depression cutoff of 14 has been used in our preliminary
studies, per NIH guidelines (NINDS).
However, the accuracy of previous approaches using AVEC to study depres-
sion were limited by the use of outdated techniques. These methods require inefficient
feature engineering, such as combining speech style, eye activity and head pose modal-
ities in a Support Vector Machine [47], inputting hand-engineered features to Random
Forests [48], using facial movement, head movement dynamics and vocal prosody with
logistic regression [49], and utilizing topic modeling-based learning [50].
Neural networks have shown far greater accuracy than the aforementioned
methods at analyzing complex behaviors, and our hypothesis is that the same will hold
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true in depression. Thus, we believe that they may outperform these previous tech-
niques in screening for depression. While, the advent of neural networks has offered
a novel opportunity to improve accuracy, current approaches using neural nets have
methodological flaws of their own. Two recent papers have used neural networks to
predict PHQ-8 scores over audio, text and visual data with a best reported Root Mean
Square Error (RMSE) of 5.4 on a 27 point scale [51, 52]. RMSE can be simply under-
stood as the average distance of a predicted value from the true value. For example, an
RMSE of 6 on a 27 point scale would indicate that the values predicted by the neural
network are on average 6 points away from the true values. Using text and audio anal-
ysis, Hanai and colleagues [53] achieved an RMSE of 6.7 on the same scale. By leaving
out video analysis, their peak RMSE and ability to expand to other areas of application
is limited. Additionally the decision to use PHQ-8 as the ground truth misses out on
the the granularity inherent to the more comprehensive BDI-II. The best predictive re-
sults were achieved by Jan et al. [54]. They used a multi-modal approach (video and
audio), used BDI-II as ground truth, and have achieved the best RMSE in the literature
(7.4 for the 63 point BDI-2 scale). However, further improvement for clinical utility will
require an algorithm to reach an RMSE of 5 or less since a BDI-II change of five points
is considered "minimally clinically significant" [55]. We believe that further improve-
ment is hampered by the small size of the AVEC training set and that the way forward
is not only refinement of the algorithm but also the creation of larger and more robust
datasets.
3.1.3 Proposed Solution
We are developing multi-modal deep neural networks to predict BDI-II scores. We in-
corporate visual and audio neural networks into a single master neural network which
combines the features and/or predicted scores of each individual model. We will also
be incorporating text-based NLP analysis in the future as well. Crucially, our models
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will make predictions using longitudinal data from multiple sessions, taking into ac-
count previous history and predictions, a novelty in this area of work. Additionally,
our data collection will alleviate data sparsity problems associated with current deep
learning models and enable more expressive models to be developed.
Our proposed technology seeks to integrate multiple inputs for predictive ca-
pability and will track individual user mood changes over time. Our approach will
improve predictive power by accounting for intra-user variation by allowing each par-
ticipant to serve as his or her own control and will help reduce the subjectivity and
inter-user variability inherent to psychiatric diagnosis.
Our work is particularly significant because, while not everyone has access to
psychiatric care or even knows if they have a developing mental health disorder, 75%
of Americans use a smartphone [56]. With minimal intrusion into individuals’ daily
lives, we believe our solution can assess mood changes longitudinally, predict signs
of an upcoming major depressive episode, monitor efficacy of treatment, and appro-
priately offer connections to care when needed. The technology will allow for more
frequent assessment of disease status than possible with often infrequent clinic visits,
and, by providing a readily available system, we can democratize mental healthcare to
the most in-need populations. This technology has the potential to significantly impact
the epidemic of undiagnosed depression.
Our technology may reveal novel insights into treatment efficacy, disease seg-
mentation, and alleviating and exacerbating environmental factors. This may be par-
ticularly useful during evaluation of patients undergoing clinical trials of novel agents.
Additionally, after developing an algorithm that can use a multimodal inputs to detect
signs of depression, we hope to expand towards screening and treatment monitoring
for other mental health disorders including burnout, bipolar disorder, schizophrenia,
Alzheimer’s, and Parkinson’s Disease. Additionally, our active methodology innova-
tion will allow us to expand our technology to the clinic and acute care settings. In
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the clinic, we imagine our active video analysis functionality to provide valuable, non-
invasive immediate diagnostic and clinical support information useful during telepsych,
telemedicine, and in-person clinical encounters. Passive tracking, such as monitoring
weeks of phone activity, will not be able to do this.
In addition to our goal of developing a "state-of-the-art" neural network to pre-
dict depression, we are also excited to develop a longitudinal audio-visual database
correlated with depression scores. This sort of data would be the first in existence,
since it has historically been very difficult to obtain. Obtaining videos that are tied to
ground truth will generate a promising source of information that can be used in later
studies outside of our own, and we believe that it could be the source of significant
academic and translational productivity both for our project and others to come.
3.2 Methods
3.2.1 Overview
As described in the introductory sections, our overall neural network analysis can cur-
rently be split primarily into video and audio analysis.
Current input data consists of videos (including audio in German) from the
academic AVEC 2014 database. It is a dataset of 150 videos (50 for training, 50 for
testing, and 50 for development) of individual people speaking to a webcam. Each
video is labelled with an individual’s BDI-II score (0-63). As mentioned before, the
actual scores range from 0 to 45, highlighting the skew towards non-depressed patients.
Currently we have two separate networks for audio and for visual data. We
are planning to output a final score by learning a weight between the scores of the two
networks and the desired BDI-II score. Another option we are considering exploring
is to see how we can combine the audio features and the video features into a single
neural network which combines features to learn BDI-II score.
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The primary future aim of this work is to obtain orders of magnitude more data
to significantly improve accuracy beyond that seen in the literature. Not only will the
quantity of data be significantly increased (one of the best ways to improve neural net
performance), but the quality will also be higher than anything previously gathered as
will be further described in section 3.2.4.
3.2.2 Video Analysis
Work for building and tuning the video neural net architecture was done primarily by
my colleague Michael Day.
A neural network was developed using Python scripts and programs using
Keras packages running on a TensorFlow backend. Specifically the neural net created
was a 19-layer convolutional neural network, a gold-standard neural network for im-
age classification and computer vision tasks.
Our network has 19 weighted layers. We apply three sets of three convolu-
tion layers with each followed by 2x2 max-pooling layer. Our 2D convolution layers
apply a 3x3 convolution with 32, 64, and 128 output filters. Then we flatten our 3D
feature maps to a 1D feature vector, and feed those vectors through two 64-node fully-
connected dense layers with 20% dropout each. The network ends with a single-node
dense layer that will output a single predicted BDI-II score per set of inputs. Dense
layers perform classification on the features extracted by the convolutional layers and
downsampled by the pooling layers. Faces are extracted from input images using Haar
cascade classifiers, and the faces are reduced to 48x48 grayscale images to improve run-
times and normalize inputs across different resolutions (per state-of-the-art practices).
The model is compiled using an Adam optimizer and measures mean squared error
as its loss metric. Activation functions primarily consisted of recitified linear units
(ReLU).
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Many different training iterations were run for hyperparameter tuning in order
to optimize the neural network’s accuracy on the test set. Tunable variables included:
number of epochs, batch size, number of samples taken per video, and data augmen-
tation features including: minimum face size, Haar cascade classifier scale factor, Haar
cascade classifier minimum number of neighbors, horizontal flip, face image rescale
size.
The optimal neural net was one in which the epochs were infinite and the model
ceased training after no improvements were made in many (unsure of number) epochs.
Only the best models having the lowest mean squared error were saved. The following
parameters were ultimately used: batch size = 128, 500 samples taken per video, mini-
mum face size = 30x30, Haar cascade classifier scale factor = 1.1, Haar cascade classifier
minimum number of neighbors =5, horizontal flip = off, face image rescale size = 48x48.
Training was performed over 781 epochs for more than 72 hours on a desktop
computer with one NVIDIA 980ti graphics card with 6 GB RAM.
3.2.3 Audio Analysis
Work for building and tuning the audio neural net architecture was done primarily by
my colleague Alexander Fabbri.
Currently the audio architectures extracts MFCC features based on the Fourier
transform of a speech signal (13 features per timestep) from the entire audio stream;
additional features including Mel-frequency cepstral coefficients (MFCCs) will be ex-
tracted moving forward. Feature selection is then completed to determine the most
relevant features. The features are then fed into a Gated Recurrence Unit (GRU) of
dimension 100 as part of a Gated Recurrence Neural Network. By training on audio
data labeled with BDI-II, our networks learn to output BDI-II scores for our test set.
Regarding the datasets, we have data split into train, development and test sets.
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Alex is currently implementing the following techniques to further improve ac-
curacy. We plan to use cross validation to examine the results of our algorithms. In the
cases where our data is skewed, we plan to explore undersampling and oversampling
methods. We will also explore binning the samples to alleviate data sparsity. However,
our end goal is to be able to perform fine-grained analysis of the spectrum of depres-
sion. Additionally, we plan to use L1 regularization, L2 regularization, their combina-
tion (also known as Elastic Nets) as well as dropout to allow better generalization of
our neural networks. We will use standard optimization techniques such as gradient
descent and its variants (Adam, AdaGrad, Nesterov gradient descent, RMSprop) as
well as cutting-edge optimization techniques such as super-convergence and 1-cycle
learning rate scheduling. Related to combining various modes of input, we would like
to analyze textual input related to BDI-II scores, either by converting speech to text and
then using Natural Language Processing techniques or through additional meta-data.
More generally, we want to explore the effect of “out of domain” data on our neural
network; how training with additional data taken from a different setting or pilot study
affect our results. We would like to see how we can unbiasedly identify subgroups of
patients. Also, we want to be able for our algorithms to continually learn and not have
to re-train our algorithms every single time a new data point is added.
3.2.4 Pilot Studies for Gathering of First-in-Class Data
Work for designing and implementing these pilot studies was done primarily by Nicholas
Chedid.
3.2.5 Need for Additional Data
The only currently openly available audiovisual datasets correlated to depression come
from AVEC and this data has several significant weaknesses, which highlight many of
the needs for additional data in this space.
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1) The AVEC datasets correlated to BDI-2 scores consist of only 150 videos; it is
a generally accepted maxim in machine learning that increasing training data is one of
the most effective ways to improve algorithm performance.
2) The audio in these videos is only in German; having audio in several lan-
guages could enhance the generalizability of our algorithms.
3) This dataset, similar to many in medical research and the facial recognition
space, consists of a relatively racially and ethnically monolithic participant popula-
tion; facial recognition algorithms and medical research in general are hampered by
non-diverse data which limits generalizability and applicability of such research. For
example, prior studies show that the accuracy of facial recognition algorithms is sensi-
tive to the demographic composition of both training and test data [57, 58]. Numerous
papers describe the importance of diverse patient populations in medical studies in
general as well [59, 60, 61]. Inclusion of minority participants in NIH funded research
continues to be an ongoing issue; for example, since the NIH passed the Revitalization
Act in 1993 to address this, less than 2% of the greater than 10,000 cancer clinical tri-
als funded by the National Cancer Institute included sufficient minority participants to
meet the NIH’s own criteria [60].
4) The AVEC database does not contain longitudinal data i.e. multiple videos
and BDI-2 scores from participants over time. We hypothesize that audiovisual data
collected longitudinally allows for more accurate prediction of BDI-II compared to data
from a single encounter. One possible reason for improved performance would be the
ability to measure a patient’s delta or relative change from assessment to assessment as
opposed to relying on just an absolute BDI-2 score.
5) The AVEC dataset lacks extreme BDI-2 scores particularly at the higher end
of scoring with the majority of scores clustered in the low to intermediate range. This
lack of data significantly hampers the ability of any algorithms trained on this data to
detect more significant depression.
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We are in the final stages of IRB approval to begin our first pilot study at Ponce
Health Sciences University in Puerto Rico to address many of these shortcomings as
seen in section 3.2.7. We are also in the process of beginning several other pilot stud-
ies to further address these issues with emergency room patients (section 3.2.8) and
medical residents (section 3.2.6).
3.2.6 Pilot Study with Medical Residents
I will begin with the development of our pilot studies with medical residents because
this was the original motivation to develop an artificial intelligence mental health screen-
ing technology. As a medical student, it was easy to see the epidemic of depression
and burnout among medical trainees. The evidence is sobering. In a meta-analysis
of 54 studies by Mata et al. published in JAMA, the estimated prevalence of depres-
sion among resident physicians was 28.8% [62]. In another multicenter-study focusing
on surgical residents by Williford et al. and published in JAMA surgery, the estimated
prevalences of burnout and depression among surgical residents were 75% and 39%
respectively [63]. For context, the estimated prevalence of depression among the gen-
eral population is approximately 9% and, more specifically, between 12-13% in adults
of residency age (25-34) [64]. Additionally, the Accreditation Council for Graduate
Medical Education (ACGME) has recently rolled out new Common Program Require-
ments that require every residency program to address physician well-being, burnout,
self-care, and mental health issues including requirements to improve mental health
screening of residents.
In addition to the aforementioned significant need for work improving mental
health in medical trainees, a pilot in this population would also address many of the
shortcomings of the AVEC dataset as described in section 3.2.5. Specifically, it would
allow us to greatly increase the quantity of our data, have data in English in addition to
German, increase ethnic and racial diversity of our data, obtain longitudinal data, and
likely gather more more varied data with possibly higher BDI-2 scores given that the
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prevalence of depression in medical trainees is more than double that of their same-age
peers (29% vs 12-13%) as described above within this same subsection.
Realizing this, I met with Dr. Rosemary Fischer, Director of Resident and Fel-
low Well-Being at Yale New Haven Hospital, to discuss implementing a pilot study to
gather additional training data to improve the accuracy of our neural networks. Fol-
lowing these discussions, I went on to give an oral presentation of our proposed pilot
study and technology at the Yale Innovation Summit where I also presented a poster
titled, Artificial Intelligence for the Detection of Psychiatric Disease, which won Best Tech
Poster.
The feedback from these presentations was invaluable. Incorporating this feed-
back, I then gave an oral presentation titled, An AI-enabled mobile gaming platform for the
early detection of psychiatric disease, at the Stanford Medicine X ED conference. There I
was fortunate to meet with the President of Ponce Health Sciences University (PHSU)
in Puerto Rico to discuss our work. Given our mutual interest in conducting a pilot
study at PHSU, he invited me to present a pilot proposal to the Deans of PHSU. This is
further discussed in section 3.2.7.
Our specific aims are:
• Specific Aim 1: Confirm that our algorithm is capable of accurately predicting
whether an individual has mild depression or greater, as defined by the BDI-II
instrument. Criteria for Acceptance: Our algorithm will achieve a sensitivity of
75% and specificity of 85% in predicting a BDI-II score greater or equal to 14.
– Rationale:
∗ A BDI-II score of 14 or greater corresponds to depression ranging from
mild to severe
∗ Primary care physicians have a sensitivity of 51% and specificity of 87%
at detecting depression without an instrument [65]
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∗ The most common screening instrument (PHQ-9) has a sensitivity of
74% and specificity of 91% at detecting depression [66]
∗ Given the above three points, we are aiming to maintain comparable
specificity while exceeding PHQ-9 and primary care sensitivity, which
is our primary focus given that we are initially developing a screening
technology
• Specific Aim 2: Demonstrate that longitudinal analysis of a user’s audiovisual
data can detect clinically important BDI-II changes. Criteria for Acceptance: Our
algorithm will predict BDI-II scores with a root mean square error (RMSE) of less
than 7.
– Rationale:
∗ The ability to measure changes over time is essential to identify at-risk
subjects who transition between depressive and non-depressive states
and monitor improvement in depressed patients undergoing treatment
∗ An approximate 5-point change in the BDI-II score corresponded to a
minimal clinically meaningful change in severity according to DSM-
IV [55]
∗ Given that a corresponding RMSE of 5 in real-world data is so far above
current standards, we are aiming for an RMSE < 7 at the conclusion
of Phase 1 of our STTR grant with the goal of reaching RMSE5 twelve
months after concluding Phase 1
Eligible participants for this study include all residents at Yale New Haven Hos-
pital. Recruitment will follow a consecutive sampling strategy with a recruitment goal
of 150 residents. We aim to have 100 medical residents complete this study, with com-
pletion defined as completing one survey per month. Participants will be reimbursed
upon completion of the study.
Chapter 3. Neural Networks for Depression Screening & Treatment Monitoring 40
Study participants will be directed to download the Sol application via an email
link. For participants who do not use a smartphone, a link to a weekly Qualtrics survey
will be provided. Via the Sol app or Qualtrics, participants will be asked to record their
answer to a simple question like, “How was your day yesterday?” There will be both
a Spanish and English version of the application and survey. Users can choose which
language they prefer. Care will be made to not ask questions that could be potentially
triggering to participants. Following completion of the video response and successful
upload (either automatically via the Sol app or manually uploaded through Qualtrics),
each participant will be presented with a BDI-2 survey. Each response will be tagged to
the associated video and delivered to secure, HIPAA compliant servers for subsequent
analysis by the predictive AI algorithms.
We are currently applying for an NIMH STTR grant to fund this pilot and the
Emergency Department pilot. Our aim is to begin this pilot in October as funds from
the grant disburse. Pilot duration will be 12 months: 3 months enrollment, 6 months
data collection, and 3 months data analysis.
3.2.7 Pilot Study at Ponce Health Sciences University
As mentioned in section 3.2.6 , I was invited to give an oral presentation to the President
and Deans of PHSU in Puerto Rico to discuss a pilot study proposal. I presented this
as: An AI technology for the screening of depression in healthcare students.
Recognizing the strong need for improved mental health among healthcare
trainees and excited by our proposal, PHSU was excited to collaborate. Two psychol-
ogy PhD students were recruited to administer and run the pilot study locally with Dr.
Nydia Ortiz, Dean of the School of Behavioral and Brain Sciences and the former Di-
rector of the Puerto Rico Mental Health and Substance Abuse Administration, serving
as the site PI.
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The data gathered from the PHSU pilot will serve to further address the weak-
nesses of the AVEC dataset and also strengthen areas of our resident pilot. Specifically,
it will allow us to increase our data size beyond what would be possible with the resi-
dent pilot, to add Spanish data to our English and German data, to even more signifi-
cantly increase the racial and ethnic diversity of our data particularly among Hispanic
participants, to obtain longitudinal data, and to likely gather more varied data with
higher BDI-2 scores than found in AVEC. The resident pilot would still likely allow
for gathering of higher BDI-2 scores given the high prevalence of depression among
resident trainees.
Our pilot is titled: An AI-enabled mobile application for the rapid assessment and risk
stratification of depression in medical professionals.
Our objectives are:
• Objective 1: Collect audiovisual data which can be used to identify patterns of
facial and linguistic expression, as well as other relevant predictors, useful in the
identification of depression in the study population
• Objective 2: Compare the effectiveness of an AI-powered facial and linguistic
analysis algorithm to detect signs of depression as compared to a BDI-2 question-
naire.
• Objective 3: Validate the feasibility and utility of rapid, automated psychiatric
risk stratification via a mobile interface
Eligible participants for this study include any healthcare students aged 21 or
older, the legal age of medical consent in Puerto Rico, enrolled at Ponce Health Sciences
University (PHSU). Recruitment will follow a consecutive sampling strategy with an
estimated sample size of 300 - 400 students. We aim to have 150 students complete
the study with completion defined as completing one survey per month. There will
be two primary arms to this study that will have equal numbers of participants: one
conducted in English and the other conducted in Spanish.
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Study participants will be directed to download the Sol application via an email
link. The application is a simple touch-based interface that will allow for the video
recording of a user. For this study this app is meant to be a data gathering tool and
not a diagnostic tool. For participants who do not use a smartphone, a link to a weekly
Qualtrics survey will be provided. There will be both a Spanish and English version
of the application and survey. During study registration, users will answer a 5-point
Likert language proficiency question for both English and Spanish, with scores ranging
from basic to native. Users who score 3 and above in only one language will complete
the study in that language. Those who score 3 and above in both English and Spanish
will be randomized and complete the study in either language.
Via the Sol app or Qualtrics, participants will be asked to record their answer
every other week to a simple question such as, “How was your day yesterday?” Care
will be made to not ask questions that could be potentially triggering to participants.
Participants will also be asked each week if they are clinically diagnosed with depres-
sion or are in treatment for depression. Following completion of the video response and
successful upload (either automatically via the Sol app or manually uploaded through
Qualtrics), each participant will be asked to complete a BDI-2 survey We anticipate the
entire interaction with the application will take approximately 5 minutes.
Each response will be tagged to the associated video and delivered to secure,
HIPAA compliant servers for subsequent analysis by the predictive AI algorithm. Servers
are specifically run through Amazon Web Services on their HIPAA secure platform.
Only the study programmers will have access to the information on these servers, as
they will use the data to improve the AI algorithm.
The IRB is in the final stages of approval. We aim to begin recruitment this
March. Pilot duration will be 6 months.
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3.2.8 Pilot Study with Yale Emergency Department Patients
As we prepared our NIMH STTR grant, we realized that one limitation of the AVEC
data was still not being sufficiently addressed by our other two pilot studies: the lack
of more extreme BDI-2 scores particularly at the higher end of scoring. This lack of
data could significantly hamper the ability of our algorithms to detect more significant
depression.A pilot study in the emergency department would allow us to selectively
recruit depressed patients to address this.
One drawback of a pilot in the emergency department would be the lack of
longitudinal data. Fortunately, this ability to provide longitudinal data is a strength of
the two previously described pilot studies. This drawback can also be seen to provide
some benefit. Namely, given the non-longitudinal nature of participation in this pilot,
which would allow for lower reimbursement per participant, it will be much easier
to have a significantly higher number of participants. So while the data may not be
longitudinal, there is benefit to be gained from having a much greater variety of faces
and voices for analysis.
Our specific aim is the same as specific aim 1 in section 3.2.6, since both pilots are part
of the same NIMH STTR grant application:
• Specific Aim 1: Confirm that our algorithm is capable of accurately predicting
whether an individual has mild depression or greater, as defined by the BDI-II
instrument. Criteria for Acceptance: Our algorithm will achieve a sensitivity of
75% and specificity of 85% in predicting a BDI-II score greater or equal to 14.
– Rationale:
∗ A BDI-II score of 14 or greater corresponds to depression ranging from
mild to severe
∗ Primary care physicians have a sensitivity of 51% and specificity of 87%
at detecting depression without an instrument [65]
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∗ The most common screening instrument (PHQ-9) has a sensitivity of
74% and specificity of 91% at detecting depression [66]
∗ Given the above three points, we are aiming to maintain comparable
specificity while exceeding PHQ-9 and primary care sensitivity, which
is our primary focus given that we are initially developing a screening
technology
Eligible participants for this study include all patients in the Yale New Haven
Hospital Emergency Department and Crisis Intervention Unit (CIU) over the age of 18
with a clinic suspicion of depression. Exclusion criteria: excessive agitation or a his-
tory of schizophrenia or schizoaffective disorder. Enrollment and data collection peri-
ods will occur simultaneously as each participant will immediately complete the study
after being enrolled (i.e. recording a video response to a question and completing the
BDI-II survey). Completing those steps will take less than 5 minutes. Participants will
be reimbursed upon completion of the study. The enrollment goal is 400 participants.
The simultaneous enrollment and data collection periods will last for 7 months.
Study participants will be directed to complete a survey on either the Sol app
or Qualtrics on one of the Emergency Department iPads designated for research. Par-
ticipants will be asked to record their answer to a simple question like, “How was your
day yesterday?” There will be both a Spanish and English version of the application
and survey. Users can choose which language they prefer. Care will be made to not
ask questions that could be potentially triggering to participants. Following comple-
tion of the video response and successful upload, each participant will be presented
with a BDI-2 survey. Each response will be tagged to the associated video and deliv-
ered to secure, HIPAA compliant servers for subsequent analysis by the predictive AI
algorithms.
We will be submitting an NIMH STTR translational grant on April 1st to fund
this pilot and the medical resident pilot. Our aim is to begin this pilot in October as
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funds from the grant disburse. Pilot duration will be 12 months: 9 months simultane-
ous enrollment and data collection and 3 months data analysis.
3.3 Results
Currently, several pilot studies have been designed. The first, our pilot study at Ponce
Health Sciences University in Puerto Rico, is aimed at acquiring more diverse data.
We are in the final stages of IRB approval and are aiming to begin recruiting in March.
Using this new data, we hope to update our neural network results prior to the start of
our other pilot studies.
Additionally, after several presentations and the associated feedback and the
formation of the several collaborations over time, we have designed two other pilot
studies incorporating medical residents and ED patients, which we are applying for an
STTR grant for in April.
The measure most commonly used to test the accuracy of a neural network is
root-mean-square error (RMSE), which is a measure of the average difference between
a predicted and actual value (BDI-II score in this case). Our previous best results are
displayed in 3.1. Our video neural network had an RMSE of 10.1 and our audio neural
network had an RMSE of 11.6 with accuracies of 74% and 70% respectively. When
considering these RMSE values, it is important to remember that the range of BDI-II
scores is from 0 to 63. In addition, what is more important than getting the BDI-II score
exactly correct is knowing clinically which individuals need help. Using a BDI-II score
of 20–which indicates moderate depression–as a cutoff, our video analysis correctly
binned users 74% of the time, and the audio analysis correctly binned users 70% of the
time.
Since then we have improved our video neural network to an RMSE of 9.53
giving us the second best values in the literature. Currently we are implementing new
architectures for our audio and video algorithms in the next few weeks and are aiming
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to begin enrollment of participants in our Puerto Rico pilot this March; these updates
will allow us to further improve our accuracy.
Another next step will be the submission of our NIMH STTR grant in April,
which has already undergone many drafts.
FIGURE 3.1: Video and Audio Neural Networks Accuracy
3.4 Discussion
Regarding, improving the performance of our neural nets: increasing the amount of
input data as our pilot studies progress would likely result in an improved model from
an increased quantity of data, quality of data (longitudinal, more diverse participants,
and more diverse BDI-2 scores including more extreme values). Future enhancements
may include a similar approach for change in pupil size over time, change in emotional
sentiment over time, minimum and maximum emotional sentiment of an entire video,
and other techniques including incorporating other meta-data such as time of day or
location or lighting when video is taken. We also plan to incorporate natural language
processing analysis of text from our audio recordings to ideally further improve accu-
racy.
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As previously described, we will be creating the first longitudinal audio-visual
database correlated with depression scores. Given the critical importance of data in
machine learning and the fact that just our Puerto Rico pilot study will provide an order
of magnitude more data than the non-longitudinal AVEC database, we are confident
that we will be able to significantly outperform current best prediction tools. We also
currently plan to incorporate the longitudinal data from our pilots studies in two ways.
First, we plan to assess not just absolute BDI-2 scores but relative changes to the delta of
their scores as another possible way for predicting depressive episodes. Additionally,
a user’s scores to any and all of these neural nets may be considered as a time-series.
For example, considering the same user’s video score over a period of weeks as they
take the test multiple times.
In summary, we aim to develop a digital biomarker for depression. Develop-
ing such a digital biomarker for depression can serve as proof of concept for AI-based
diagnosis, disease segmentation, and monitoring of other mental health disorders and
of non-psychiatric diseases. Our platform will allow us to identify objective nuances in
subjectively established psychiatric disease categories and facilitate personalized treat-
ment regimens. Currently, the evaluation of chronic diseases such as depression relies
on longitudinal evaluation. The active, video nature of our technology offers the po-
tential to rapidly assess depression and other diseases instantaneously unlike current
passive techniques. Furthermore, audiovisual samples may yield valuable insights into
complex disorders such as burnout, bipolar disorder, schizophrenia, Alzheimer’s Dis-
ease, and potentially non-psychiatric conditions including Parkinson’s Disease, cere-
brovascular accidents, and myocardial infarctions. Finally, our platform could be use-
ful for screening, diagnosis, treatment monitoring, and patient selection and monitor-
ing in clinical trials of novel agents.
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